Search Results - "Elekhnawy, Engy"

Refine Results
  1. 1

    Histological assessment, anti-quorum sensing, and anti-biofilm activities of Dioon spinulosum extract: in vitro and in vivo approach by Elekhnawy, Engy, Negm, Walaa A., El-Aasr, Mona, Kamer, Amal Abo, Alqarni, Mohammed, Batiha, Gaber El-Saber, Obaidullah, Ahmad J., Fawzy, Heba M.

    Published in Scientific reports (07-01-2022)
    “…Pseudomonas aeruginosa is an opportunistic bacterium causing several health problems and having many virulence factors like biofilm formation on different…”
    Get full text
    Journal Article
  2. 2

    An investigation of the impact of triclosan adaptation on Proteus mirabilis clinical isolates from an Egyptian university hospital by Elekhnawy, Engy, Sonbol, Fatma, Abdelaziz, Ahmed, Elbanna, Tarek

    Published in Brazilian journal of microbiology (01-06-2021)
    “…Antibiotic resistance is a main threat to the public health. It is established that the overuse and misuse of antibiotics are highly contributing to antibiotic…”
    Get full text
    Journal Article
  3. 3

    Antibacterial and Antibiofilm Effects of Allelopathic Compounds Identified in Medicago sativa L. Seedling Exudate against Escherichia coli by Abouzeid, Sara, Beutling, Ulrike, Elekhnawy, Engy, Selmar, Dirk

    Published in Molecules (Basel, Switzerland) (14-03-2023)
    “…In this study, the allelopathic properties of L. (alfalfa) seedling exudates on the germination of seeds of various species were investigated. The compounds…”
    Get full text
    Journal Article
  4. 4

    The potential application of probiotics for the prevention and treatment of COVID-19 by Elekhnawy, Engy, Negm, Walaa A

    Published in Egyptian Journal of Medical Human Genetics (25-03-2022)
    “…Background Given the severe infection, poor prognosis, and the low number of available effective drugs, potential prevention and treatment strategies for…”
    Get full text
    Journal Article
  5. 5

    Investigation of the Antibacterial Activity and Efflux Pump Inhibitory Effect of Cycas thouarsii R.Br. Extract against Klebsiella pneumoniae Clinical Isolates by Negm, Walaa A., El-Aasr, Mona, Kamer, Amal Abo, Elekhnawy, Engy

    Published in Pharmaceuticals (Basel, Switzerland) (01-08-2021)
    “…The vast spread of multidrug-resistant bacteria has encouraged researchers to explore new antimicrobial compounds. This study aimed to investigate the…”
    Get full text
    Journal Article
  6. 6

    Elucidation of the Metabolite Profile of Yucca gigantea and Assessment of Its Cytotoxic, Antimicrobial, and Anti-Inflammatory Activities by Attallah, Nashwah G M, El-Sherbeni, Suzy A, El-Kadem, Aya H, Elekhnawy, Engy, El-Masry, Thanaa A, Elmongy, Elshaymaa I, Altwaijry, Najla, Negm, Walaa A

    Published in Molecules (Basel, Switzerland) (16-02-2022)
    “…The acute inflammation process is explained by numerous hypotheses, including oxidative stress, enzyme stimulation, and the generation of pro-inflammatory…”
    Get full text
    Journal Article
  7. 7

    Zinc Oxide Nanoparticles as Potential Delivery Carrier: Green Synthesis by Aspergillus niger Endophytic Fungus, Characterization, and In Vitro/In Vivo Antibacterial Activity by Abdelkader, Dalia H, Negm, Walaa A, Elekhnawy, Engy, Eliwa, Duaa, Aldosari, Basmah N, Almurshedi, Alanood S

    Published in Pharmaceuticals (Basel, Switzerland) (26-08-2022)
    “…We aimed to synthesize zinc oxide nanoparticles (ZnO NPs) using the endophytic fungal extract of Aspergillus niger. The prepared ZnO NPs were characterized,…”
    Get full text
    Journal Article
  8. 8

    In Vivo and In Vitro Antimicrobial Activity of Biogenic Silver Nanoparticles against Staphylococcus aureus Clinical Isolates by Attallah, Nashwah G M, Elekhnawy, Engy, Negm, Walaa A, Hussein, Ismail A, Mokhtar, Fatma Alzahraa, Al-Fakhrany, Omnia Momtaz

    Published in Pharmaceuticals (Basel, Switzerland) (03-02-2022)
    “…can cause a wide range of severe infections owing to its multiple virulence factors in addition to its resistance to multiple antimicrobials; therefore, novel…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Evaluation of the impact of adaptation of Klebsiella pneumoniae clinical isolates to benzalkonium chloride on biofilm formation by Elekhnawy, Engy A, Sonbol, Fatma I, Elbanna, Tarek E, Abdelaziz, Ahmed A

    Published in Egyptian Journal of Medical Human Genetics (27-05-2021)
    “…Background The percentage of the multidrug resistant Klebsiella pneumoniae clinical isolates is increasing worldwide. The excessive exposure of K. pneumoniae…”
    Get full text
    Journal Article
  11. 11

    Antidiarrheal and Antibacterial Activities of Monterey Cypress Phytochemicals: In Vivo and In Vitro Approach by Elmongy, Elshaymaa I, Negm, Walaa A, Elekhnawy, Engy, El-Masry, Thanaa A, Attallah, Nashwah G M, Altwaijry, Najla, Batiha, Gaber El-Saber, El-Sherbeni, Suzy A

    Published in Molecules (Basel, Switzerland) (06-01-2022)
    “…Monterey cypress ( ) is a decorative plant; however, it possesses various pharmacological activities. Therefore, we explored the phytochemical profile of root…”
    Get full text
    Journal Article
  12. 12

    Aqueous core epigallocatechin gallate PLGA nanocapsules: characterization, antibacterial activity against uropathogens, and in vivo reno-protective effect in cisplatin induced nephrotoxicity by Alotaibi, Badriyah, El-Masry, Thanaa A., Elekhnawy, Engy, El-Kadem, Aya H., Saleh, Asmaa, Negm, Walaa A., Abdelkader, Dalia H.

    Published in Drug delivery (01-12-2022)
    “…Epigallocatechin-3-gallate (EGCG) was isolated from Cycas thouarsii leaves for the first time and encapsulated in aqueous core poly(lactide-co-glycolide)…”
    Get full text
    Journal Article
  13. 13

    Traditional herbs against COVID-19: back to old weapons to combat the new pandemic by Al-kuraishy, Hayder M, Al-Fakhrany, Omnia Momtaz, Elekhnawy, Engy, Al-Gareeb, Ali I, Alorabi, Mohammed, De Waard, Michel, Albogami, Sarah M, Batiha, Gaber El-Saber

    Published in European journal of medical research (26-09-2022)
    “…Abstract Background Recently, the coronavirus (COVID-19) pandemic is a chief public health disaster caused by severe acute respiratory syndrome coronavirus 2…”
    Get full text
    Journal Article
  14. 14

    Present and future treatment strategies for coronavirus disease 2019 by Elekhnawy, Engy, Kamar, Amal Abo, Sonbol, Fatma

    Published in Future journal of pharmaceutical sciences (09-04-2021)
    “…Background The recent pandemic of coronavirus disease 2019 (COVID-19) has resulted in many challenges to the healthcare organizations around the world…”
    Get full text
    Journal Article
  15. 15

    Potential impact of biocide adaptation on selection of antibiotic resistance in bacterial isolates by Elekhnawy, Engy, Sonbol, Fatma, Abdelaziz, Ahmed, Elbanna, Tarek

    Published in Future journal of pharmaceutical sciences (21-11-2020)
    “…Background Antibiotic resistance in pathogenic bacterial isolates has increased worldwide leading to treatment failures. Main body Many concerns are being…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Insight into Fucoidan-Based PEGylated PLGA Nanoparticles Encapsulating Methyl Anthranilic Acid: In Vitro Evaluation and In Vivo Anti-Inflammatory Study by Abdelkader, Dalia H, Elekhnawy, Engy, Negm, Walaa A, El-Masry, Thanaa A, Almukainzi, May, Zayed, Ahmed, Ulber, Roland

    Published in Marine drugs (01-11-2022)
    “…A potential fucoidan-based PEGylated PLGA nanoparticles (NPs) offering a proper delivery of N-methyl anthranilic acid (MA, a model of hydrophobic…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Antibacterial and wound healing potential of biosynthesized zinc oxide nanoparticles against carbapenem-resistant Acinetobacter baumannii: an in vitro and in vivo study by Selim, Mohamed I, Sonbol, Fatma I, El-Banna, Tarek E, Negm, Walaa A, Elekhnawy, Engy

    Published in Microbial cell factories (16-10-2024)
    “…Carbapenem-resistant Acinetobacter baumannii denotes a significant menace to public health, and it mandates an urgent development of new effective medications…”
    Get full text
    Journal Article
  20. 20

    Investigation of the impact of rosuvastatin and telmisartan in doxorubicin-induced acute cardiotoxicity by Al-Kuraishy, Hayder M, Al-Gareeb, Ali I, Alkhuriji, Afrah Fahad, Al-Megrin, Wafa Abdullah I, Elekhnawy, Engy, Negm, Walaa A, De Waard, Michel, Batiha, Gaber El-Saber

    Published in Biomedicine & pharmacotherapy (01-10-2022)
    “…Cardiac injury is the main dose-limiting factor for doxorubicin (Dox) use as an anticancer agent. The cardiotoxicity of Dox is linked to a number of complex…”
    Get full text
    Journal Article